Clinical trial
Remicade Infusion Management Program
NCT00723905 is registered in ClinicalTrials.gov with Janssen Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Remicade Infusion Management Program
- Lead sponsor
- Janssen Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- October 31, 2012
- Enrollment
- 1,630 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.